The study is designed to assess the efficacy of Glatiramer Acetate (GA) injection 40 mg
administered three times a week compared to placebo in subjects with RRMS, as measured by
the number of confirmed relapses during the 12 month placebo controlled phase. The study has
two phases:
- Placebo Controlled Phase: 12 months of 40 mg administered three times a week by
- Open Label Extension: All subjects will continue treatment with GA 40 mg administered
three times a week, until this dose strength is commercially available for the
treatment of relapsing remitting multiple sclerosis (RRMS) patients or until the
development of this GA dose regimen is stopped by the Sponsor
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Both.
Teva Investigational Site 5940, Blagoevgrad, Bulgaria
Teva Investigational Site 5931, Pleven, Bulgaria
Teva Investigational Site 5932, Pleven, Bulgaria
Teva Investigational Site 5933, Plovdiv, Bulgaria
Teva Investigational Site 5936, Ruse, Bulgaria
Teva Investigational Site 5935, Shumen, Bulgaria
Teva Investigational Site 5921, Sofia, Bulgaria
Teva Investigational Site 5922, Sofia, Bulgaria
Teva Investigational Site 5923, Sofia, Bulgaria
Teva Investigational Site 5924, Sofia, Bulgaria
Teva Investigational Site 5925, Sofia, Bulgaria
Teva Investigational Site 5926, Sofia, Bulgaria
Teva Investigational Site 5927, Sofia, Bulgaria
Teva Investigational Site 5928, Sofia, Bulgaria
Teva Investigational Site 5929, Sofia, Bulgaria
Teva Investigational Site 5938, Sofia, Bulgaria
Teva Investigational Site 5939, Sofia, Bulgaria
Teva Investigational Site 5934, Stara Zagora, Bulgaria
Teva Investigational Site 5930, Varna, Bulgaria
Teva Investigational Site 5937, Veliko Tarnovo, Bulgaria
Teva Investigational Site 6011, Osijek, Croatia
Teva Investigational Site 6009, Zagreb, Croatia
Teva Investigational Site 6010, Zagreb, Croatia
Teva Investigational Site 6012, Zagreb, Croatia
Teva Investigational Site 6013, Zagreb, Croatia
Teva Investigational Site 5433, Olomouc, Czech Republic
Teva Investigational Site 5434, Ostrava - poruba, Czech Republic
Teva Investigational Site 5435, Teplice, Czech Republic
Teva Investigational Site 5513, Kohtla-Jaerve, Estonia
Teva Investigational Site 5510, Tallinn, Estonia
Teva Investigational Site 5512, Tartu, Estonia
Teva Investigational Site 8110, Tbilisi, Georgia
Teva Investigational Site 8111, Tbilisi, Georgia
Teva Investigational Site 3268, Bad Wildbad, Germany
Teva Investigational Site 3272, Bayreuth, Germany
Teva Investigational Site 3262, Berlin, Germany
Teva Investigational Site 3276, Berlin, Germany
Teva Investigational Site 3265, Dresden, Germany
Teva Investigational Site 3263, Erbach, Germany
Teva Investigational Site 3266, Hannover, Germany
Teva Investigational Site 3270, Herborn, Germany
Teva Investigational Site 3275, Marburg, Germany
Teva Investigational Site 3264, Ulm, Germany
Teva Investigational Site 5127, Budapest, Hungary
Teva Investigational Site 5129, Debrecen, Hungary
Teva Investigational Site 5130, Eger, Hungary
Teva Investigational Site 5132, Esztergom, Hungary
Teva Investigational Site 5131, Gyor, Hungary
Teva Investigational Site 5128, Kaposvar, Hungary
Teva Investigational Site 5133, Veszprem, Hungary
Teva Investigational Site 3089, Bologna, Italy
Teva Investigational Site 3084, Cefalù (Palermo), Italy
Teva Investigational Site 3080, Milano, Italy
Teva Investigational Site 3086, Roma, Italy
Teva Investigational Site 5710, Kaunas, Lithuania
Teva Investigational Site 5712, Siauliai, Lithuania
Teva Investigational Site 5711, Vilnius, Lithuania
Teva Investigational Site 5374, Czestochowa, Poland
Teva Investigational Site 5377, Elblag, Poland
Teva Investigational Site 5380, Gdansk, Poland
Teva Investigational Site 5381, Gdansk, Poland
Teva Investigational Site 5376, Gorzow Wielkopolski, Poland
Teva Investigational Site 5372, Grodzisk Mazowiecki, Poland
Teva Investigational Site 5368, Katowice, Poland
Teva Investigational Site 5375, Katowice, Poland
Teva Investigational Site 5379, Kielce, Poland
Teva Investigational Site 5382, Konskie, Poland
Teva Investigational Site 5369, Koscierzyna, Poland
Teva Investigational Site 5378, Krakow, Poland
Teva Investigational Site 5366, Lodz, Poland
Teva Investigational Site 5373, Olsztyn, Poland
Teva Investigational Site 5384, Poznan, Poland
Teva Investigational Site 5371, Szczecin, Poland
Teva Investigational Site 5367, Warszawa, Poland
Teva Investigational Site 5370, Wroclaw, Poland
Teva Investigational Site 5233, Balotesti, Romania
Teva Investigational Site 5220, Bucuresti, Romania
Teva Investigational Site 5221, Bucuresti, Romania
Teva Investigational Site 5227, Cluj-Napoca, Romania
Teva Investigational Site 5230, Cluj-Napoca, Romania
Teva Investigational Site 5225, Constanta, Romania
Teva Investigational Site 5226, Constanta, Romania
Teva Investigational Site 5232, Craiova, Romania
Teva Investigational Site 5231, Iasi, Romania
Teva Investigational Site 5223, Piatra-Neamt, Romania
Teva Investigational Site 5228, Sibiu, Romania
Teva Investigational Site 5229, Targu-Mures, Romania
Teva Investigational Site 5224, Timisoara, Romania
Teva Investigational Site 5063, Barnaul, Russian Federation
Teva Investigational Site 5059, Ekaterinburg, Russian Federation
Teva Investigational Site 5068, Irkutsk, Russian Federation
Teva Investigational Site 5067, Krasnoyarsk, Russian Federation
Teva Investigational Site 5052, Moscow, Russian Federation
Teva Investigational Site 5057, Nizhny Novgorod, Russian Federation
Teva Investigational Site 5062, Novosibirsk, Russian Federation
Teva Investigational Site 5060, Perm, Russian Federation
Teva Investigational Site 5053, Saint Petersburg, Russian Federation
Teva Investigational Site 5058, Samara, Russian Federation
Teva Investigational Site 5838, Simferopol, AR Crimea, Russian Federation
Teva Investigational Site 5064, Smolensk, Russian Federation
Teva Investigational Site 5054, St. Petersburg, Russian Federation
Teva Investigational Site 5055, St. Petersburg, Russian Federation
Teva Investigational Site 5056, St. Petersburg, Russian Federation
Teva Investigational Site 5066, Tomsk, Russian Federation
Teva Investigational Site 5061, Ufa, Russian Federation
Teva Investigational Site 5065, Yaroslavl, Russian Federation
Teva Investigational Site 9020, Johannesburg, South Africa
Teva Investigational Site 9022, Pietermaritzburg, South Africa
Teva Investigational Site 9018, Pretoria, South Africa
Teva Investigational Site 9021, Rosebank, South Africa
Teva Investigational Site 5835, Chernihiv, Ukraine
Teva Investigational Site 5834, Chernivtsi, Ukraine
Teva Investigational Site 5827, Dnipropetrovsk, Ukraine
Teva Investigational Site 5828, Donetsk, Ukraine
Teva Investigational Site 5829, Ivano-Frankivsk, Ukraine
Teva Investigational Site 5830, Kharkiv, Ukraine
Teva Investigational Site 5833, Kyiv, Ukraine
Teva Investigational Site 5836, Kyiv, Ukraine
Teva Investigational Site 5825, Lviv, Ukraine
Teva Investigational Site 5839, Odesa, Ukraine
Teva Investigational Site 5832, Poltava, Ukraine
Teva Investigational Site 5837, Uzhgorod, Ukraine
Teva Investigational Site 5826, Vinnytsya, Ukraine
Teva Investigational Site 5831, Zaporizhzhya, Ukraine
Teva Investigational Site 3438, Salford, United Kingdom
Teva Investigational Site 3440, Sheffield, United Kingdom
Teva Investigational Site 1327, Gilbert, Arizona, United States
Teva Investigational Site 1311, Phoenix, Arizona, United States
Teva Investigational Site 1326, Fullerton, California, United States
Teva Investigational Site 1335, La Jolla, California, United States
Teva Investigational Site 1297, Aurora, Colorado, United States
Teva Investigational Site 1344, Boulder, Colorado, United States
Teva Investigational Site 1315, Centennial, Colorado, United States
Teva Investigational Site 1345, Miami, Florida, United States
Teva Investigational Site 1336, Naples, Florida, United States
Teva Investigational Site 1347, Pompano Beach, Florida, United States
Teva Investigational Site 1298, Sarasota, Florida, United States
Teva Investigational Site 1316, Sarasota, Florida, United States
Teva Investigational Site 1340, Tampa, Florida, United States
Teva Investigational Site 1317, Vero Beach, Florida, United States
Teva Investigational Site 8052, Tel Hashomer, IL, Israel
Teva Investigational Site 1303, Northbrook, Illinois, United States
Teva Investigational Site 1302, Lexington, Kentucky, United States
Teva Investigational Site 1322, Shreveport, Louisiana, United States
Teva Investigational Site 1306, Detroit, Michigan, United States
Teva Investigational Site 1329, Akron, Ohio, United States
Teva Investigational Site 1349, Columbus, Ohio, United States
Teva Investigational Site 1313, Dayton, Ohio, United States
Teva Investigational Site 1318, Uniontown, Ohio, United States
Teva Investigational Site 1341, Oklahoma City, Oklahoma, United States
Teva Investigational Site 1310, Nashville, Tennessee, United States
Teva Investigational Site 1321, Lubbock, Texas, United States
Teva Investigational Site 1301, San Antonio, Texas, United States
Teva Investigational Site 1346, San Antonio, Texas, United States
Teva Investigational Site 1343, Salt Lake City, Utah, United States
Teva Investigational Site 1338, Richmond, Virginia, United States
Teva Investigational Site 1339, Roanoke, Virginia, United States
Teva Investigational Site 1300, Vienna, Virginia, United States
Teva Investigational Site 1323, Kirkland, Washington, United States